Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:22 Issue:1 Number:1 ISSN#:2563-5476
ACE Report #13444
Ace Report Cover Foot & Ankle

Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis

How to Cite

OrthoEvidence. Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis. ACE Report. 2021;22(1):1. Available from: https://myorthoevidene.com/AceReport/Report/13444

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of Botulinum Toxin A, Corticosteroid, and Anesthetic Injection for Plantar Fasciitis

Foot Ankle Int. 2021 Mar;42(3): 305-313.

Contributing Authors: J Elizondo-Rodríguez M Simental-Mendía V Peña-Martínez F Vilchez-Cavazos Y Tamez-Mata C Acosta-Olivo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seventy-one patients with ≥2 months of persisting heel pain at the origin of the plantar fascia unresponsive to conventional therapies were randomized to receive a single injection of ropivacaine (5 mL; n=23), an intra-lesional injection of betamethasone sodium phosphate (1 mL; n=25), or an intralesional injection of 200 U of botulinum toxin A (BoNT-A; n=23) injection, administered using ultrasoun...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.